CS16 COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75319-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)75319-5/fulltext
Title :
CS16 COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75319-5&doi=10.1016/S1098-3015(10)75319-5
First page :
Section Title :
Open access? :
No
Section Order :
1240